Browse by Medical Category
Accepting New Patients
Dr. Brad Dickerson is a behavioral neurologist dedicated to the sophisticated, compassionate, multidisciplinary care of patients with neurodegenerative disorders. He is also a neuroscientist aiming to improve the diagnosis and care of patients.
Go To Programs
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Brad Dickerson, MD is Associate Professor of Neurology at Harvard Medical School and Director of the Front otemporal Disorders Unit at the Massachusetts General Hospital, an integrated multidisciplinary unit dedicated to the highest level of care of patients with these conditions. Dr. Dickerson is also on staff as a behavioral neurologist in the MGH Memory Disorders Unit.Dr. Dickerson is an active clinical consultant in many aspects of cognitive and behavioral neurology of neurodegenerative and related disorders, including frontotemporal dementia, primary progressive aphasia, Alzheimer's, mild cognitive impairment, posterior cortical atrophy, and related conditions, and the use of neuroimaging and other diagnostic markers in neurodegenerative diseases.
Dr. Dickerson has published extensively in the field of neurodegenerative disease, neuroimaging, aging, and cognitive neuroscience. He is on the advisory board of the Massachusetts Alzheimer's Association and the national Association for FTD. He is active in teaching, leading an annual course on Cognitive Neurology at the American Academy of Neurology and co-directing the annual Harvard Dementia Course. He is also an active mentor of trainees in neurology, psychiatry, and psychology, and of graduate and medical students, as well as undergraduate and high school students interested in this field.
Dr. Dickerson has published more than 70 manuscripts and book chapters and is in the process of editing 2 textbooks in the field of cognitive neurology and dementia, and runs a brain imaging laboratory affiliated with the Martinos Center for Biomedical Imaging.
In Brad Dickerson's Laboratory, we seek to understand the relationships between brain anatomy, physiology, and behavior in humans across the lifespan and in those with neurodegenerative diseases. Major focus areas of our research include: memory abilities and the brain systems that subserve them in normal individuals and how these abilities and brain systems change with aging, Alzheimer's disease, and related disorders (including frontotemporal dementias and posterior cortical atrophy); understanding how aging, Alzheimer's disease, and related disorders alter the normal anatomy and function of the human brain, and determining whether this knowledge can assist in diagnosis and monitoring of these conditions; and the further development of new neuroimaging and behavioral technology for making quantitative measurements of these abilities and brain systems. We are also pursuing studies of language and semantic knowledge in progressive aphasias; and social cognition and affective processing in normal aging and how these are affected by frontotemporal dementias and Alzheimer's disease. In addition, we pursue some investigations related to the development and promotion of capacities to compensate for age- and disease-related changes.
View my most recent publications at PubMed
A study by Massachusetts General Hospital investigators examines a group of older adults whose memory performance is equivalent to that of younger individuals and finds that key areas of their brains resemble those of young people.
In 2012, Katie Brandt, a community resource specialist in the Neurology Department at the MGH, lost her husband to frontotemperal dementia (FTD). This gradually progressive fatal brain disease is very rare, and affects a person&rsquo;s core self and relationships.
Subtle differences in brain anatomy among older individuals with normal cognitive skills may be able to predict both the risk of developing Alzheimer's disease in the following decade and how quickly symptoms of dementia would develop.
In the most comprehensive study to date, neurologists have clearly identified significant differences in the ways that Alzheimer&rsquo;s disease (AD) affects patients with and without the apolipoprotein E &epsilon;4 gene, a known genetic risk factor for the neurodegenerative disease.
A gripping story of a young man diagnosed with Frontal Temporal Dementia by Dr. Brad Dickerson.
Back to Top